Remdesivir Entèmedyè CAS 1354823-36-1 COVID-19 N-[(S)-(4-nitrophenoxy)phenoxyphosphinyl]-L-Alanine 2-ethylbutyl ester
Manifakti Komèsyal Pwovizyon pou Remdesivir ak entèmedyè ki gen rapò ak kalite siperyè
Remdesivir CAS 1809249-37-3
2-Ethyl-1-butanol CAS 97-95-0
Trimethylsilil Cyanide CAS 7677-24-9
4-Nitrophenol CAS 100-02-7
2-Ethylbutil ((S)-(perfluorophenoxy)(phenoxy)phosphoryl)-L-alaninate CAS 1911578-98-7
N-[(S)-(4-nitrophenoxy)phenoxyphosphinyl]-L-Alanine 2-ethylbutyl ester CAS 1354823-36-1
(S)-2-Ethylbutyl 2-Aminopropanoate Hydrochloride CAS 946511-97-3
Remdesivir metabolit (GS-441524) CAS 1191237-69-0
Remdesivir N-2 Entèmedyè CAS 1191237-80-5
2,3,5-Tri-O-benzyl-D-ribonolactone CAS 55094-52-5
7-Bromopyrrolo [2,1-f][1,2,4] triazin-4-amine CAS 937046-98-5
Pyrrolo [1,2-F][1,2,4] Triazin-4-Amine CAS 159326-68-8
4-Amino-7-yodopyrrolo[2,1-f][1,2,4]triazine CAS 1770840-43-1
Non Chimik | N-[(S)-(4-nitrophenoxy)phenoxyphosphinyl]-L-Alanine 2-ethylbutyl ester |
Sinonim | Remdesivir Entèmedyè;Remdesivir Side Chain;Remdesivir p-NitroPhenoxy L-Alanine enpurte;Remdesivir enpurte 4;Remdesivir-002;(S)-2-Etilbutil 2-(((S)-(4-nitrophenoxy)(phenoxy)-phosphoryl)-amino)propanoate |
Nimewo CAS | 1354823-36-1 |
Nimewo CAT | RF-PI297 |
Estati Stock | Nan stock, pwodiksyon echèl jiska dè santèn de kilogram |
Fòmil molekilè | C21H27N2O7P |
Pwa molekilè | 450,42 |
Mak | Ruifu Chimik |
Atik | Espesifikasyon |
Aparans | Poud blan pou prèske blan |
Idantifikasyon | IR, HPLC |
Pèt sou siye | ≤1.0% |
Single enpurte | ≤0.50% |
Metal lou | ≤20ppm |
Pite | ≥98.0% |
Tès Creole | Enterprise Standard |
Itilizasyon | Entèmedyè nan Remdesivir (CAS 1809249-37-3);KOVID 19 |
Pake: Boutèy, sak papye aliminyòm, tanbou katon, 25kg / tanbou, oswa selon kondisyon kliyan an.
Kondisyon Depo:Sere nan resipyan ki fèmen nan yon kote ki fre ak sèk;Pwoteje kont limyè, imidite ak ensèk nuizib.
N-[(S)-(4-nitrophenoxy)phenoxyphosphinyl]-L-Alanine 2-ethylbutyl ester (CAS 1354823-36-1, ke yo rele tou Remdesivir Impurite 4) se yon chenn phosphoramidate tipikman itilize pou preparasyon Remdesivir (CAS). 1809249-37-3, GS-5734), ki se yon nouvo dwòg antiviral ankèt okòmansman pou tretman maladi viris Ebola ak enfeksyon viris Marburg epi ki answit yo te jwenn tou ki montre aktivite antiviral kont coronavirus (egzanp SARS-Cov-2/). Kovid 19).Pandan epidemi nouvo Maladi Coronavirus 2019 (COVID-19), Remdesivir (CAS 1809249-37-3) se youn nan pwodwi rechèch ki gen rapò ak COVID-19.Remdesivir, ki te vann anba non mak Veklury, se yon gwo spectre medikaman antiviral devlope pa konpayi biopharmaceutique Gilead Sciences.Li se administre atravè piki nan yon venn.Pandan pandemi COVID-19, Remdesivir te apwouve oswa otorize pou itilize ijans pou trete COVID-19 nan anviwon 50 peyi.Mizajou direktiv Òganizasyon Mondyal Lasante an Novanm 2020 gen ladan yon rekòmandasyon kondisyonèl kont itilizasyon Remdesivir pou tretman COVID-19.